205 related articles for article (PubMed ID: 37674200)
21. Prognostic implication of molecular subtypes and response to neoadjuvant chemotherapy in 760 gastric carcinomas: role of Epstein-Barr virus infection and high- and low-microsatellite instability.
Kohlruss M; Grosser B; Krenauer M; Slotta-Huspenina J; Jesinghaus M; Blank S; Novotny A; Reiche M; Schmidt T; Ismani L; Hapfelmeier A; Mathias D; Meyer P; Gaida MM; Bauer L; Ott K; Weichert W; Keller G
J Pathol Clin Res; 2019 Oct; 5(4):227-239. PubMed ID: 31206244
[TBL] [Abstract][Full Text] [Related]
22. The importance of Epstein-Barr virus infection in the systemic treatment of patients with gastric cancer.
Pikuła A; Kwietniewska M; Rawicz-Pruszyński K; Ciseł B; Skórzewska M; Gęca K; Franciszkiewicz-Pietrzak K; Kurylcio A; Mielko J; Polkowski WP
Semin Oncol; 2020; 47(2-3):127-137. PubMed ID: 32402473
[TBL] [Abstract][Full Text] [Related]
23. Genomic and epigenomic heterogeneity in molecular subtypes of gastric cancer.
Lim B; Kim JH; Kim M; Kim SY
World J Gastroenterol; 2016 Jan; 22(3):1190-201. PubMed ID: 26811657
[TBL] [Abstract][Full Text] [Related]
24. Multiancestry genomic and transcriptomic analysis of gastric cancer.
Totoki Y; Saito-Adachi M; Shiraishi Y; Komura D; Nakamura H; Suzuki A; Tatsuno K; Rokutan H; Hama N; Yamamoto S; Ono H; Arai Y; Hosoda F; Katoh H; Chiba K; Iida N; Nagae G; Ueda H; Shihang C; Sekine S; Abe H; Nomura S; Matsuura T; Sakai E; Ohshima T; Rino Y; Yeoh KG; So J; Sanghvi K; Soong R; Fukagawa A; Yachida S; Kato M; Seto Y; Ushiku T; Nakajima A; Katai H; Tan P; Ishikawa S; Aburatani H; Shibata T
Nat Genet; 2023 Apr; 55(4):581-594. PubMed ID: 36914835
[TBL] [Abstract][Full Text] [Related]
25. Genomics Study of Gastric Cancer and Its Molecular Subtypes.
Yuen ST; Leung SY
Adv Exp Med Biol; 2016; 908():419-39. PubMed ID: 27573784
[TBL] [Abstract][Full Text] [Related]
26. A novel genomic classification system of gastric cancer via integrating multidimensional genomic characteristics.
Wang H; Ding Y; Chen Y; Jiang J; Chen Y; Lu J; Kong M; Mo F; Huang Y; Zhao W; Fang P; Chen X; Teng X; Xu N; Lu Y; Yu X; Li Z; Zhang J; Wang H; Bao X; Zhou D; Chi Y; Zhou T; Zhou Z; Chen S; Teng L
Gastric Cancer; 2021 Nov; 24(6):1227-1241. PubMed ID: 34095982
[TBL] [Abstract][Full Text] [Related]
27. Lymphocyte-rich gastric cancer: associations with Epstein-Barr virus, microsatellite instability, histology, and survival.
Grogg KL; Lohse CM; Pankratz VS; Halling KC; Smyrk TC
Mod Pathol; 2003 Jul; 16(7):641-51. PubMed ID: 12861059
[TBL] [Abstract][Full Text] [Related]
28. Prognostic value of tumor-infiltrating lymphocytes in Epstein-Barr virus-associated gastric cancer.
Kang BW; Seo AN; Yoon S; Bae HI; Jeon SW; Kwon OK; Chung HY; Yu W; Kang H; Kim JG
Ann Oncol; 2016 Mar; 27(3):494-501. PubMed ID: 26673353
[TBL] [Abstract][Full Text] [Related]
29. Identification of three immune subtypes characterized by distinct tumor immune microenvironment and therapeutic response in stomach adenocarcinoma.
Zhu Y; Zhao Y; Cao Z; Chen Z; Pan W
Gene; 2022 Apr; 818():146177. PubMed ID: 35065254
[TBL] [Abstract][Full Text] [Related]
30. Prognostic and immune infiltration significance of ARID1A in TCGA molecular subtypes of gastric adenocarcinoma.
Zhang Z; Li Q; Sun S; Ye J; Li Z; Cui Z; Liu Q; Zhang Y; Xiong S; Zhang S
Cancer Med; 2023 Aug; 12(16):16716-16733. PubMed ID: 37366273
[TBL] [Abstract][Full Text] [Related]
31. The viral expression and immune status in human cancers and insights into novel biomarkers of immunotherapy.
Chen S; Lai H; Zhao J; Chen B; Li Y; Li Y; Li Q; Zheng Q; Huang S; Zhu X
BMC Cancer; 2021 Nov; 21(1):1183. PubMed ID: 34740324
[TBL] [Abstract][Full Text] [Related]
32. Epstein-Barr Virus-Associated Gastric Carcinoma: Use of Host Cell Machineries and Somatic Gene Mutations.
Abe H; Kaneda A; Fukayama M
Pathobiology; 2015; 82(5):212-23. PubMed ID: 26337667
[TBL] [Abstract][Full Text] [Related]
33. The Transcriptomic Landscape of Gastric Cancer: Insights into Epstein-Barr Virus Infected and Microsatellite Unstable Tumors.
Gullo I; Carvalho J; Martins D; Lemos D; Monteiro AR; Ferreira M; Das K; Tan P; Oliveira C; Carneiro F; Oliveira P
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30018250
[TBL] [Abstract][Full Text] [Related]
34. Molecular characterization of gastric adenocarcinoma diagnosed in patients previously treated for Hodgkin lymphoma or testicular cancer.
Rigter LS; Snaebjornsson P; Rosenberg EH; Altena E; van Grieken NCT; Aleman BMP; Kerst JM; Morton L; Schaapveld M; Meijer GA; van Leeuwen FE; van Leerdam ME;
PLoS One; 2022; 17(7):e0270591. PubMed ID: 35877698
[TBL] [Abstract][Full Text] [Related]
35. Subtraction of Epstein-Barr virus and microsatellite instability genotypes from the Lauren histotypes: Combined molecular and histologic subtyping with clinicopathological and prognostic significance validated in a cohort of 1,248 cases.
Huang SC; Ng KF; Yeh TS; Cheng CT; Lin JS; Liu YJ; Chuang HC; Chen TC
Int J Cancer; 2019 Dec; 145(12):3218-3230. PubMed ID: 30771224
[TBL] [Abstract][Full Text] [Related]
36. Novel Therapeutic Approaches for Epstein-Barr Virus Associated Gastric Cancer.
Kang BW; Baek DW; Kang H; Baek JH; Kim JG
Anticancer Res; 2019 Aug; 39(8):4003-4010. PubMed ID: 31366481
[TBL] [Abstract][Full Text] [Related]
37. PIK3CA mutation subtype delineates distinct immune profiles in gastric carcinoma.
Choi S; Kim H; Heo YJ; Kang SY; Ahn S; Lee J; Kim KM
J Pathol; 2023 Aug; 260(4):443-454. PubMed ID: 37341658
[TBL] [Abstract][Full Text] [Related]
38. Intratumoral Immune Response to Gastric Cancer Varies by Molecular and Histologic Subtype.
Kim TS; da Silva E; Coit DG; Tang LH
Am J Surg Pathol; 2019 Jun; 43(6):851-860. PubMed ID: 30969179
[TBL] [Abstract][Full Text] [Related]
39. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
[TBL] [Abstract][Full Text] [Related]
40. A lepidic gene signature predicts patient prognosis and sensitivity to immunotherapy in lung adenocarcinoma.
Nguyen TT; Lee HS; Burt BM; Wu J; Zhang J; Amos CI; Cheng C
Genome Med; 2022 Jan; 14(1):5. PubMed ID: 35016696
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
